• SGI-1027: DNA Methyltransferase Inhibitor Workflows in Cance

  2026-07-08

  SGI-1027, a potent DNA methyltransferase inhibitor, is redefining cancer epigenetics research by enabling robust gene reactivation and reliable DNA methylation inhibition. This article details actionable protocols, workflow improvements, and troubleshooting strategies that maximize the impact of SGI-1027 in advanced cancer models.

• Single-Nucleus Profiling Reveals ATRNL1's Role in Atrial Fib

  2026-07-07

  This study applies large-scale single-nucleus RNA sequencing to human atrial tissue, uncovering cell type-specific gene dysregulation in atrial fibrillation (AF). The identification of ATRNL1 as a modulator of cardiomyocyte stress and conduction provides a new molecular target with implications for future therapeutic strategies.

• Vacuolin-1: Unveiling Lysosomal Exocytosis in Developmental

  2026-07-07

  Explore how Vacuolin-1, a selective lysosomal exocytosis inhibitor, drives new understanding of lysosome-mediated signaling in skeletal pathology and membrane repair. This article reveals unique protocol insights and translational research opportunities you won't find elsewhere.

• Machine Learning for Mechanism-of-Action Prediction Across C

  2026-07-06

  Warchal et al. systematically compared ensemble-based tree classifiers and convolutional neural networks (CNNs) in predicting drug mechanisms of action (MoAs) from high-content imaging data across diverse breast cancer cell lines. Their findings reveal that while CNNs and classical models perform equally well within individual cell lines, ensemble tree classifiers better generalize when applied to unseen cell types—highlighting key challenges for translational phenotypic profiling.

• CHIR-99021: Precision GSK-3 Inhibition in Stem Cell Workflow

  2026-07-06

  CHIR-99021 (CT99021) enables precise control over stem cell fate by selectively inhibiting GSK-3, unlocking robust pluripotency maintenance and directed differentiation. This article details best practices for leveraging CHIR-99021 in experimental protocols, highlights troubleshooting strategies, and distills key innovations from its use in regenerative models.

• Perphenazine: Dopamine D2 Receptor Antagonist in Advanced Re

  2026-07-05

  Perphenazine's unique receptor profile and mitochondria-mediated effects position it as a premier dopamine D2 receptor antagonist for both neuropharmacology and host-directed antibacterial studies. This article details robust workflows, optimization strategies, and experimental innovations leveraging Perphenazine from APExBIO.

• Energy Deficiency, ATG4B, and DNA Repair Disruption in AML P

  2026-07-04

  This study reveals that energy deficiency drives ATG4B nuclear translocation, which directly impairs PRMT1-mediated DNA repair in acute myeloid leukemia (AML) cells, promoting genomic instability and leukemia progression. Targeting ATG4B restores DNA repair capacity, reduces mutation burden, and prolongs survival in preclinical AML models, providing a mechanistic link between cellular metabolism and genome maintenance.

• Etomoxir in Immunometabolism: Protocol, Application & Troubl

  2026-07-03

  Etomoxir (R-(+)-Etomoxir) has become an indispensable tool for interrogating the fatty acid oxidation pathway in both immune and metabolic disorder research. This article unpacks standardized workflows, advanced use-cases, and evidence-based troubleshooting tips, translating the latest protocols into practical guidance for maximizing data quality in whole-blood and cellular assays.

• FKBP9 Drives Glioblastoma Malignancy and ER Stress Resistanc

  2026-07-03

  Xu et al. (2020) reveal that FKBP9 amplifies glioblastoma progression by promoting malignant phenotypes and conferring resistance to endoplasmic reticulum stress. Their study elucidates FKBP9’s role in p38MAPK and IRE1α-XBP1 signaling, providing new insights for therapeutic targeting and experimental modeling of ER stress responses.

• C8-HSL Drives Lung Cancer Progression via PI3K/AKT/ERK Activ

  2026-07-02

  This study reveals that N-octanoyl-L-Homoserine lactone (C8-HSL), a bacterial quorum-sensing molecule, promotes proliferation, migration, and invasion of lung cancer cells through activation of the PI3K/AKT/ERK pathway. These findings highlight a direct mechanistic link between bacterial signaling metabolites and tumor progression, suggesting new targets for cancer intervention and microbiota monitoring.

• Ellagic Acid for CK2 Inhibition: Workflows & Troubleshooting

  2026-07-02

  Ellagic acid’s selectivity as an ATP-competitive CK2 inhibitor empowers precision in cancer biology and oxidative stress assays. This guide delivers actionable protocols, advanced use-cases, and troubleshooting tips—bridging the latest AI-driven senolytic discovery with reproducible experimental design.

• IBDV VP3-Mediated IRF7 Degradation: Mechanism of Viral Immun

  2026-07-01

  This study elucidates how infectious bursal disease virus (IBDV) leverages its VP3 protein to promote the proteasomal degradation of interferon regulatory factor 7 (IRF7), thereby suppressing host antiviral responses and facilitating viral replication in chicken cells. The findings reveal a direct interaction between VP3 and IRF7, providing novel mechanistic insight into avian viral immune evasion and highlighting the importance of the ubiquitin-proteasome system in viral pathogenesis.

• Amyloid β-Peptide (1-42): Optimized Workflows for AD Researc

  2026-07-01

  Harness Amyloid β-Peptide (1-42) for robust modeling of Alzheimer's pathology with advanced workflows and troubleshooting tips. Discover how ratiometric imaging and high-fidelity neurotoxicity assays are transforming neurodegeneration research.

• Viperin Disrupts Coronavirus RTC via nsp8: Conserved Antivir

  2026-06-30

  The reference study uncovers a conserved antiviral mechanism by which viperin inhibits coronavirus replication. By directly binding viral non-structural protein 8 (nsp8), viperin disrupts the assembly of the replication-transcription complex, providing new insight for broad-spectrum RNA virus replication inhibitors and informing antiviral drug development.

• SR-202 (PPAR antagonist): Reliable PPARγ Inhibition for Meta

  2026-06-30

  This article presents a scenario-driven, evidence-based guide to using SR-202 (PPAR antagonist) (SKU B6929) in metabolic and immunometabolic research. Through real laboratory challenges and validated solutions, we illustrate how SR-202 enhances assay reproducibility and mechanistic insight, making it a trusted tool for researchers studying adipogenesis, insulin resistance, and macrophage polarization.

451 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page